Novel anti-4-1BB×PD-L1 bispecific antibody augments anti-tumor immunity through tumor-directed T-cell activation and checkpoint blockade

por Jeong, Seongju, Park, Eunyoung, Kim, Hyung-Don, Sung, Eunsil, Kim, Hyunjoo, Jeon, Jaehyoung, Kim, Youngkwang, Jung, Ui-jung, Son, Yong-Gyu, Hong, Youngeun, Lee, Hanbyul, Lee, Shinai, Lim, Yangmi, Won, Jonghwa, Jeon, Minwoo, Hwang, Shin, Fang, Lei, Jiang, Wenqing, Wang, Zhengyi, Shin, Eui-Cheol, Park, Su-Hyung, Jung, Jaeho
Publicado 2021

LAG-3xPD-L1 bispecific antibody potentiates antitumor responses of T cells through dendritic cell activation

por Sung, Eunsil, Ko, Minkyung, Won, Ju-young, Jo, Yunju, Park, Eunyoung, Kim, Hyunjoo, Choi, Eunji, Jung, Ui-jung, Jeon, Jaehyoung, Kim, Youngkwang, Ahn, Hyejin, Choi, Da-som, Choi, Seunghyun, Hong, Youngeun, Park, Hyeyoung, Lee, Hanbyul, Son, Yong-Gyu, Park, Kyeongsu, Won, Jonghwa, Oh, Soo Jin, Lee, Seonmin, Kim, Kyu-pyo, Yoo, Changhoon, Song, Hyun Kyu, Jin, Hyung-seung, Jung, Jaeho, Park, Yoon
Publicado 2022